Not Found
On Demand

Fatty Liver: Do We Need to Worry About It?

Total Credits: 1.25 including 1.25 AOA Category 1-A Credit(s), 1.25 AMA PRA Category 1 Credit(s)™

Average Rating:
State Associations:
AOMA - Arizona
David Leff, DO
Never expires.


Fatty Liver: Do We Need to Worry About It?

David Leff, DO

  • Appreciate the burden and consequences of fatty liver disease in America
  • Develop a treatment plan for fatty liver
  • Demonstrate the need for tertiary referral

Dr. Leff discloses that he is on the speakers’ bureau for Gilead, Abbvie, Allergan

The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. The AOMA designates this program for a maximum of 1.25 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.

The Arizona Osteopathic Medical Association (AOMA) designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W Camelback Rd, Suite 105, Phoenix, AZ 85015 or by email to




David Leff, DO Related seminars and products

Central Arizona Medical Associates

David Leff, DO is a board certified gastroenterologist in private practice in Mesa, Arizona. He is an Adjunct Assistant Professor, Division of Clinical Education, Midwestern University - Arizona College of Osteopathic Medicine. Dr Leff is a graduate of Des Moines University and he completed his Internal Medicine residency and Gastroenterology fellowship at the Western Pennsylvania Hospital in Pittsburgh. During his fellowship he was involved with early Hepatitis C treatment options. He currently serves on the Medical Advisory Committee for the American Liver Foundation – Arizona Chapter. Dr. Leff speaks for a number of different pharmaceutical companies on the topics of hepatitis C and irritable bowel syndrome.


Dr. Leff discloses that he is a member of the Speakers Bureau for Gilead Sciences and AbbVie.

Please wait ...

Back to Top